Teva Pharmaceuticals USA announces the availability of Indapamide Tablets USP, 1.25 mg. This new strength joins Indapamide Tablets USP, 2.5 mg in Teva's product line. It is AB rated and bioequivalent to Rhone-Poulenc Rorer's Lozol. Indapamide Tablets 1.25 mg and 2.5 mg are available in bottles of 100 and 1,000.
"Teva USA's Indapamide Tablets offer a cost-savings alternative to the brand product," said Larry Rosenthal, vice president of sales. "Our company is committed to developing and marketing generic products at competitive prices for our customers. We want our customers to benefit from our expanding product line and our focus on customer service."
For more information, contact Gene Cioschi at (888) TEVA- USA.
COPYRIGHT 1998 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group
Contact
Home
A
Ibuprofen